Table 1 Clinicopathological features of subjects enrolled in this study
Characteristics | Tissues | Urine samples |
|---|---|---|
Healthy control | - | 93 |
Sex – no. (%) | ||
 Male | - | 60 (64.5) |
 Female | - | 33 (35.5) |
Age, mean (range) | - | 53.8 (26–85) |
BUD | - | 48a |
Sex – no. (%) | ||
 Male | - | 29 (60.4) |
 Female | - | 19 (39.6) |
Age, mean (range) | - | 52.5 (34 – 83) |
Bladder cancer (BCa) | 9 | 71 |
Sex – no. (%) | ||
 Male | 7 (77.8) | 55 (77.5) |
 Female | 2 (22.2) | 16 (22.5) |
Age, mean (range) | 74.3 (62—81) | 68.8 (33 – 85) |
Pathological stage – no. (%) | ||
 Ta | - | 28 (39.4) |
 T1 | 5 (55.6) | 35 (49.3) |
 T2 | 1 (11.1) | 4 (5.6) |
 T3 | 1 (11.1) | 2 (2.8) |
 T4 | 2 (22.2) | 2 (2.8) |
Differentiation grade – no. (%) |  |  |
 Low | 4 (44.4) | 35 (49.3) |
 High | 5 (55.6) | 33 (46.5) |
 Unknown | - | 3 (4.2) |